Contract development for strain improvement (CRO) *Approximately 20,000 preserved strains available
Rich experience and achievements! Contracted research and development that meets the needs of a wide range of clients.
In "Contract Research Organization (CRO) for Strain Improvement and Fermentation Process Development," partner companies have accumulated extensive experience and achievements in the improvement of production strains for useful substances and recombinant technology, providing research and development services that meet the diverse needs of a wide range of clients. We possess a library of 20,000 strains that produce useful substances. We offer comprehensive and high-quality services regarding strain improvement, in vivo changes, fermentation process development, and the provision of microbial NP libraries. 【Features】 ○ Improvement of metabolite yields ○ Suppression of by-product production ○ Enhancement of fermentation processes ○ Provision of microbial libraries ○ Extensive experience with a wide range of strains For more details, please contact us or download the catalog.
Inquire About This Product
basic information
【Services Offered】 ○ Increase desirable metabolites of microorganisms ○ Reduce impurities and by-products ○ Lower production costs ○ Stabilize production strains ○ Mitigate issues related to viscosity, aeration, or shear stress ○ Supply a microbial NP (Natural Products) library ○ Conduct experiments using bacteria, actinomycetes, fungi, yeast, anaerobic microorganisms, and genetically engineered strains ● For more details, please contact us or download the catalog.
Price information
Please contact us.
Delivery Time
※Please contact us.
Applications/Examples of results
For more details, please contact us or download the catalog.
catalog(1)
Download All CatalogsCompany information
Libra Medicina Co., Ltd. aims to contribute to the improvement of health and quality of life for people around the world by being involved in the creation of innovative pharmaceuticals and medical devices through development support services and licensing activities, delivering hope to patients suffering from serious diseases.